Pneumonia Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews
Cochrane Systematic Review: Fluid therapy for bacterial meningitis
Cochrane Systematic Review: Fluid therapy for bacterial meningitis
- Visit
Bjerre LM, Verheij TJ, Kochen MM. Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002109. do...
Bjerre LM, Verheij TJ, Kochen MM. Antibiotics for community acquired pneumon...
OBJECTIVES: To summarize current evidence from randomized controlled trials (RCTs) concerning the efficacy of different antibiotic treatments for CAP in participants older than 12.
OBJECTIVES: To summarize current evidence from randomized controlled trials (RCTs) concerning the efficacy of different antibiotic treatments for CAP in participants older than 12.
Cochrane Systematic Review: Antibiotics for preventing complications in children with measles
Cochrane Systematic Review: Antibiotics for preventing complications in children with measles
- Visit
Kabra SK, Lodha R
Kabra SK, Lodha R
OBJECTIVES: To assess the effects of antibiotics given to children with measles to prevent complications and reduce pneumonia, other morbidities and mortality.
OBJECTIVES: To assess the effects of antibiotics given to children with measles to prevent complications and reduce pneumonia, other morbidities and mortality.
Cochrane Systematic Review: Azithromycin for respiratory tract infections
Cochrane Systematic Review: Azithromycin for respiratory tract infections
- Visit
Panpanich R, Lerttrakarnnon P, Laopaiboon M
Panpanich R, Lerttrakarnnon P, Laopaiboon M
OBJECTIVES: To compare the effectiveness of azithromycin to amoxycillin or amoxycillin/clavulanic acid (amoxyclav) in the treatment of LRTI, in terms of clinical failure, incidence of adverse events and microbial eradication.
OBJECTIVES: To compare the effectiveness of azithromycin to amoxycillin or amoxycillin/clavulanic acid (amoxyclav) in the treatment of LRTI, in terms of clinical failure, incidence of adverse events and microbial eradication.
Cochrane Systematic Review: Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia
Cochrane Systematic Review: Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia
- Visit
Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A.
Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A.
Objectives: The objectives of this review are (i) to assess the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae in children and adolescents with community-acquired pneumonia; and (ii) to assess the influence of potential sources of heterogeneity on the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae.
Objectives: The objectives of this review are (i) to assess the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae in children and adolescents with community-acquired pneumonia; and (ii) to assess the influence of potential sources of heterogeneity on the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae.
Cochrane Systematic Review: Corticosteroids for pneumonia
Cochrane Systematic Review: Corticosteroids for pneumonia
- Visit
Chen Y, Li K, Pu H, Wu T.
Chen Y, Li K, Pu H, Wu T.
Objectives: To assess the efficacy and safety of corticosteroids in the treatment of pneumonia.
Objectives: To assess the efficacy and safety of corticosteroids in the treatment of pneumonia.
Cochrane Systematic Review: Oral antibiotics versus parenteral antibiotics for severe pneumonia in children
Cochrane Systematic Review: Oral antibiotics versus parenteral antibiotics for severe pneumonia in children
- Visit
Rojas MX, Granados C.
Rojas MX, Granados C.
Objectives: To determine the equivalence in effectiveness and safety of oral antibiotic compared to parenteral antibiotic therapies in the treatment of severe pneumonia in children between three months and five years of age.
Objectives: To determine the equivalence in effectiveness and safety of oral antibiotic compared to parenteral antibiotic therapies in the treatment of severe pneumonia in children between three months and five years of age.
Cochrane Systematic Review: Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
Cochrane Systematic Review: Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
- Visit
Chang CC, Cheng AC, Chang AB.
Chang CC, Cheng AC, Chang AB.
Objectives: To evaluate the efficacy of OTC cough medications as an adjunct to antibiotics in children and adults with pneumonia.
Objectives: To evaluate the efficacy of OTC cough medications as an adjunct to antibiotics in children and adults with pneumonia.
Cochrane Systematic Review: Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months
Cochrane Systematic Review: Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months
- Visit
Kozyrskyj A, Klassen TP, Moffatt M, Harvey K.
Kozyrskyj A, Klassen TP, Moffatt M, Harvey K.
Objectives: To determine the effectiveness of a short course of antibiotics (less than seven days) in comparison to a long course of antibiotics (seven days or greater) for the treatment of AOM in children.
Objectives: To determine the effectiveness of a short course of antibiotics (less than seven days) in comparison to a long course of antibiotics (seven days or greater) for the treatment of AOM in children.
Cochrane Systematic Review: Vitamin A for non-measles pneumonia in children
Cochrane Systematic Review: Vitamin A for non-measles pneumonia in children
- Visit
Ni J,Wei J,Wu T.
Ni J,Wei J,Wu T.
Objectives: To determine whether adjunctive vitamin A is effective in infants and children diagnosed with non-measles pneumonia.
Objectives: To determine whether adjunctive vitamin A is effective in infants and children diagnosed with non-measles pneumonia.
Cochrane Systematic Review: Vitamin A for treating measles in children
Cochrane Systematic Review: Vitamin A for treating measles in children
- Visit
Huiming Y, Chaomin W, Meng M.
Huiming Y, Chaomin W, Meng M.
Objectives: To determine whether vitamin A therapy, commenced after measles has been diagnosed, is beneficial in preventing mortality, pneumonia and other secondary complications in children.
Objectives: To determine whether vitamin A therapy, commenced after measles has been diagnosed, is beneficial in preventing mortality, pneumonia and other secondary complications in children.
Cochrane Systematic Review: Vitamin C for preventing and treating pneumonia
Cochrane Systematic Review: Vitamin C for preventing and treating pneumonia
- Visit
Hemil H, Louhiala P.
Hemil H, Louhiala P.
Objectives: To assess the prophylactic and therapeutic effects of vitamin C on pneumonia.
Objectives: To assess the prophylactic and therapeutic effects of vitamin C on pneumonia.
Cochrane Systematic Review: Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
Cochrane Systematic Review: Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
- Visit
Haider BA, Lassi ZS, Ahmed A, Bhutta ZA.
Haider BA, Lassi ZS, Ahmed A, Bhutta ZA.
Objectives: To evaluate zinc supplementation, as an adjunct to antibiotics, in the treatment (clinical recovery) of pneumonia in children aged two to 59 months.
Objectives: To evaluate zinc supplementation, as an adjunct to antibiotics, in the treatment (clinical recovery) of pneumonia in children aged two to 59 months.
Cochrane Systematic Review: Antibiotics for treating community acquired pneumonia in people with sickle cell disease
Cochrane Systematic Review: Antibiotics for treating community acquired pneumonia in people with sickle cell disease
- Visit
Mart-Carvajal AJ, Conterno LO
Mart-Carvajal AJ, Conterno LO
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
Cochrane Systematic Review: Fluid therapy for bacterial meningitis
Cochrane Systematic Review: Fluid therapy for bacterial meningitis
- Visit
Bjerre LM, Verheij TJ, Kochen MM. Antibiotics for community acquired pneumonia in adult outpatients. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD002109. do...
Bjerre LM, Verheij TJ, Kochen MM. Antibiotics for community acquired pneumon...
OBJECTIVES: To summarize current evidence from randomized controlled trials (RCTs) concerning the efficacy of different antibiotic treatments for CAP in participants older than 12.
OBJECTIVES: To summarize current evidence from randomized controlled trials (RCTs) concerning the efficacy of different antibiotic treatments for CAP in participants older than 12.
Cochrane Systematic Review: Antibiotics for preventing complications in children with measles
Cochrane Systematic Review: Antibiotics for preventing complications in children with measles
- Visit
Kabra SK, Lodha R
Kabra SK, Lodha R
OBJECTIVES: To assess the effects of antibiotics given to children with measles to prevent complications and reduce pneumonia, other morbidities and mortality.
OBJECTIVES: To assess the effects of antibiotics given to children with measles to prevent complications and reduce pneumonia, other morbidities and mortality.
Cochrane Systematic Review: Azithromycin for respiratory tract infections
Cochrane Systematic Review: Azithromycin for respiratory tract infections
- Visit
Panpanich R, Lerttrakarnnon P, Laopaiboon M
Panpanich R, Lerttrakarnnon P, Laopaiboon M
OBJECTIVES: To compare the effectiveness of azithromycin to amoxycillin or amoxycillin/clavulanic acid (amoxyclav) in the treatment of LRTI, in terms of clinical failure, incidence of adverse events and microbial eradication.
OBJECTIVES: To compare the effectiveness of azithromycin to amoxycillin or amoxycillin/clavulanic acid (amoxyclav) in the treatment of LRTI, in terms of clinical failure, incidence of adverse events and microbial eradication.
Cochrane Systematic Review: Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia
Cochrane Systematic Review: Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents with community-acquired pneumonia
- Visit
Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A.
Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A.
Objectives: The objectives of this review are (i) to assess the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae in children and adolescents with community-acquired pneumonia; and (ii) to assess the influence of potential sources of heterogeneity on the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae.
Objectives: The objectives of this review are (i) to assess the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae in children and adolescents with community-acquired pneumonia; and (ii) to assess the influence of potential sources of heterogeneity on the diagnostic accuracy of symptoms and signs in the clinical recognition of M. pneumoniae.
Cochrane Systematic Review: Corticosteroids for pneumonia
Cochrane Systematic Review: Corticosteroids for pneumonia
- Visit
Chen Y, Li K, Pu H, Wu T.
Chen Y, Li K, Pu H, Wu T.
Objectives: To assess the efficacy and safety of corticosteroids in the treatment of pneumonia.
Objectives: To assess the efficacy and safety of corticosteroids in the treatment of pneumonia.
Cochrane Systematic Review: Oral antibiotics versus parenteral antibiotics for severe pneumonia in children
Cochrane Systematic Review: Oral antibiotics versus parenteral antibiotics for severe pneumonia in children
- Visit
Rojas MX, Granados C.
Rojas MX, Granados C.
Objectives: To determine the equivalence in effectiveness and safety of oral antibiotic compared to parenteral antibiotic therapies in the treatment of severe pneumonia in children between three months and five years of age.
Objectives: To determine the equivalence in effectiveness and safety of oral antibiotic compared to parenteral antibiotic therapies in the treatment of severe pneumonia in children between three months and five years of age.
Cochrane Systematic Review: Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
Cochrane Systematic Review: Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
- Visit
Chang CC, Cheng AC, Chang AB.
Chang CC, Cheng AC, Chang AB.
Objectives: To evaluate the efficacy of OTC cough medications as an adjunct to antibiotics in children and adults with pneumonia.
Objectives: To evaluate the efficacy of OTC cough medications as an adjunct to antibiotics in children and adults with pneumonia.
Cochrane Systematic Review: Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months
Cochrane Systematic Review: Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months
- Visit
Kozyrskyj A, Klassen TP, Moffatt M, Harvey K.
Kozyrskyj A, Klassen TP, Moffatt M, Harvey K.
Objectives: To determine the effectiveness of a short course of antibiotics (less than seven days) in comparison to a long course of antibiotics (seven days or greater) for the treatment of AOM in children.
Objectives: To determine the effectiveness of a short course of antibiotics (less than seven days) in comparison to a long course of antibiotics (seven days or greater) for the treatment of AOM in children.
Cochrane Systematic Review: Vitamin A for non-measles pneumonia in children
Cochrane Systematic Review: Vitamin A for non-measles pneumonia in children
- Visit
Ni J,Wei J,Wu T.
Ni J,Wei J,Wu T.
Objectives: To determine whether adjunctive vitamin A is effective in infants and children diagnosed with non-measles pneumonia.
Objectives: To determine whether adjunctive vitamin A is effective in infants and children diagnosed with non-measles pneumonia.
Cochrane Systematic Review: Vitamin A for treating measles in children
Cochrane Systematic Review: Vitamin A for treating measles in children
- Visit
Huiming Y, Chaomin W, Meng M.
Huiming Y, Chaomin W, Meng M.
Objectives: To determine whether vitamin A therapy, commenced after measles has been diagnosed, is beneficial in preventing mortality, pneumonia and other secondary complications in children.
Objectives: To determine whether vitamin A therapy, commenced after measles has been diagnosed, is beneficial in preventing mortality, pneumonia and other secondary complications in children.
Cochrane Systematic Review: Vitamin C for preventing and treating pneumonia
Cochrane Systematic Review: Vitamin C for preventing and treating pneumonia
- Visit
Hemil H, Louhiala P.
Hemil H, Louhiala P.
Objectives: To assess the prophylactic and therapeutic effects of vitamin C on pneumonia.
Objectives: To assess the prophylactic and therapeutic effects of vitamin C on pneumonia.
Cochrane Systematic Review: Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
Cochrane Systematic Review: Zinc supplementation as an adjunct to antibiotics in the treatment of pneumonia in children 2 to 59 months of age
- Visit
Haider BA, Lassi ZS, Ahmed A, Bhutta ZA.
Haider BA, Lassi ZS, Ahmed A, Bhutta ZA.
Objectives: To evaluate zinc supplementation, as an adjunct to antibiotics, in the treatment (clinical recovery) of pneumonia in children aged two to 59 months.
Objectives: To evaluate zinc supplementation, as an adjunct to antibiotics, in the treatment (clinical recovery) of pneumonia in children aged two to 59 months.
Cochrane Systematic Review: Antibiotics for treating community acquired pneumonia in people with sickle cell disease
Cochrane Systematic Review: Antibiotics for treating community acquired pneumonia in people with sickle cell disease
- Visit
Mart-Carvajal AJ, Conterno LO
Mart-Carvajal AJ, Conterno LO
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
OBJECTIVES: To determine the efficacy and safety of the antibiotic treatment approaches (monotherapy or combined) for people with sickle cell disease suffering from community-acquired pneumonia.
